A

Ascendis Pharma A/S
D

ASND

152.440
USD
-2.39
(-1.54%)
مغلق
حجم التداول
10,340
الربح لكل سهم
-4
العائد الربحي
-
P/E
-22
حجم السوق
9,122,558,384
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AAL
    -0.635
    (-4.00%)
    15.225 USD
    AMP
    AMP
    -10.08
    (-1.86%)
    530.93 USD
    B
    BFS
    -0.240
    (-0.67%)
    35.750 USD
    C
    CF
    -2.350
    (-2.93%)
    77.900 USD
    ETN
    ETN
    -11.69
    (-3.78%)
    297.31 USD
    O
    OCFC
    -0.310
    (-1.72%)
    17.710 USD
    T
    TKR
    -2.510
    (-3.00%)
    81.280 USD
    المزيد
الأخبار
المقالات

العنوان: Ascendis Pharma A/S

القطاع: Healthcare
الصناعة: Biotechnology
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.